M. Pazdur

发表

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

S. Steinberg, J. Schlom, W. Dahut, 2008, Clinical Cancer Research.

Phase I trial of an enhanced prostate-specific antigen-based vaccine and anti-CTLA-4 antibody in patients with metastatic androgen-independent prostate cancer.

J. Schlom, W. Dahut, M. Theoret, 2007, Clinical genitourinary cancer.

A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

S. Steinberg, J. Schlom, R. Madan, 2011, Clinical Cancer Research.

Clinical safety of a viral vector based prostate cancer vaccine strategy.

S. Steinberg, H. Parnes, J. Schlom, 2007, The Journal of urology.

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.

S. Steinberg, J. Schlom, E. Jones, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

S. Steinberg, H. Parnes, J. Schlom, 2010, Cancer Immunology, Immunotherapy.

A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).

J. Gulley, P. Arlen, M. Pazdur, 2006, Clinical breast cancer.

A Randomized Phase II Study of Concurrent Docetaxel Plus Vaccine Versus VaccineAlone in Metastatic Androgen-Independent Prostate Cancer

J. Schlom, Clara C. Chen, W. Dahut, 2006 .

ARandomized Phase II Study of Concurrent Docetaxel Plus Vaccine Versus VaccineAlone inMetastatic Androgen-Independent Prostate Cancer

S. Steinberg, J. Schlom, Clara C. Chen, 2006 .

Vaccines: An Innovative Approach to Treating Cancer

J. Jones, M. Pazdur, 2007, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

A randomized pilot study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen independent prostate cancer.

J. Schlom, W. Dahut, J. Gulley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of sequential vaccinations with recombinant Fowlpox-PSA (L155)-TRICOM (rF)alone, or in combination with recombinant vaccinia-PSA (L155)-TRICOM (rV), and the role of GM-CSF, in patients (Pts) with prostate cancer.

J. Schlom, W. Dahut, K. Tsang, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot study of a PANVAC-V and PANVAC-F in patients (pts) with metastatic carcinoma.

J. Schlom, W. Dahut, J. Jones, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PANVAC vaccine alone or with docetaxel for patients with metastatic breast cancer

J. Schlom, R. Madan, J. Gulley, 2008 .